A novel polypeptide complex

The present disclosure relates to a novel polypeptide complex. Specifically, the present disclosure relates to a domain-modified antibody in which at least one constant region domain CH1 and/or CL of the antibody is replaced, and the domain CH1/CL is replaced by Titin T chain/Obscurin-O chain or rep...

Full description

Saved in:
Bibliographic Details
Main Authors YING, HUA, TAO, WEI-KANG, SHI, JIN-PING, HU, QI-YUE, QIN, QIAN-SHAN, MAO, LANG-YONG, LI, TING-TING, JIN, XIN-SHENG, ZHANG, LING, LAI, WEI-MING
Format Patent
LanguageChinese
English
Published 01.08.2021
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to a novel polypeptide complex. Specifically, the present disclosure relates to a domain-modified antibody in which at least one constant region domain CH1 and/or CL of the antibody is replaced, and the domain CH1/CL is replaced by Titin T chain/Obscurin-O chain or replaced by Titin T chain/Obscurin-like-O chain.
Bibliography:Application Number: TW202110100845